Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker’s top-selling antipsychotic Abilify.
For information on rights and reprints, contact subscriptions@lawyerly.com.au